These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 12516524)

  • 21. Opioid receptors and their ligands.
    Janecka A; Fichna J; Janecki T
    Curr Top Med Chem; 2004; 4(1):1-17. PubMed ID: 14754373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mimics of the binding sites of opioid receptors obtained by molecular imprinting of enkephalin and morphine.
    Andersson LI; Müller R; Vlatakis G; Mosbach K
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4788-92. PubMed ID: 7761401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Opioid receptors--structures, functions and distributions].
    Minami M; Satoh M
    Seikagaku; 1994 Aug; 66(8):1134-8. PubMed ID: 7963853
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of conformational restriction and molecular modeling techniques in the development of receptor-specific opioid peptide agonists and antagonists.
    Schiller PW; Nguyen TM; Weltrowska G; Chung NN; Lemieux C; Marsden BJ; Wilkes BC
    NIDA Res Monogr; 1993; 134():238-52. PubMed ID: 8289881
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family.
    Chen Y; Fan Y; Liu J; Mestek A; Tian M; Kozak CA; Yu L
    FEBS Lett; 1994 Jun; 347(2-3):279-83. PubMed ID: 8034018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Josef Rudinger Memorial Lecture 2002. The chemistry of the opioid receptor binding sites.
    Medzihradszky K
    J Pept Sci; 2003 Jun; 9(6):333-53. PubMed ID: 12846480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular biology of opioid receptors.
    Reisine T; Bell GI
    Trends Neurosci; 1993 Dec; 16(12):506-10. PubMed ID: 7509520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discriminative disulfide-bonding affinity labeling of opioid receptor subtypes.
    Shirasu N; Shimohigashi Y
    J Biochem Biophys Methods; 2001 Oct; 49(1-3):587-606. PubMed ID: 11694304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Endomorphins in pain relief. New endogenous peptides a sensational discovery].
    Nyberg F
    Lakartidningen; 1997 Sep; 94(36):3019-21. PubMed ID: 9312621
    [No Abstract]   [Full Text] [Related]  

  • 30. Computational structural biology of opioid receptors.
    Provasi D
    Methods Mol Biol; 2015; 1230():13-38. PubMed ID: 25293313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ZFOR2, a new opioid receptor-like gene from the teleost zebrafish (Danio rerio).
    Barrallo A; González-Sarmiento R; Alvar F; Rodríguez RE
    Brain Res Mol Brain Res; 2000 Dec; 84(1-2):1-6. PubMed ID: 11113526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the role of extracellular loops of opioid receptors in conferring ligand selectivity.
    Metzger TG; Ferguson DM
    FEBS Lett; 1995 Nov; 375(1-2):1-4. PubMed ID: 7498453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid receptors: Structural and mechanistic insights into pharmacology and signaling.
    Shang Y; Filizola M
    Eur J Pharmacol; 2015 Sep; 763(Pt B):206-13. PubMed ID: 25981301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homology models of mu-opioid receptor with organic and inorganic cations at conserved aspartates in the second and third transmembrane domains.
    Zhorov BS; Ananthanarayanan VS
    Arch Biochem Biophys; 2000 Mar; 375(1):31-49. PubMed ID: 10683246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of 5-substituted tetrahydronaphthalen-2yl-methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligands.
    Deekonda S; Wugalter L; Kulkarni V; Rankin D; Largent-Milnes TM; Davis P; Bassirirad NM; Lai J; Vanderah TW; Porreca F; Hruby VJ
    Bioorg Med Chem; 2015 Sep; 23(18):6185-94. PubMed ID: 26299827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topographical requirements for delta opioid ligands: common structural features of dermenkephalin and deltorphin.
    Misicka A; Lipkowski AW; Horvath R; Davis P; Kramer TH; Yamamura HI; Hruby VJ
    Life Sci; 1992; 51(13):1025-32. PubMed ID: 1326067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular cloning of opioid receptors by cDNA library screening.
    Pan YX
    Methods Mol Med; 2003; 84():3-16. PubMed ID: 12703312
    [No Abstract]   [Full Text] [Related]  

  • 38. Oligomerization of opioid receptors: generation of novel signaling units.
    Levac BA; O'Dowd BF; George SR
    Curr Opin Pharmacol; 2002 Feb; 2(1):76-81. PubMed ID: 11786312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the "address" recognition locus.
    Metzger TG; Paterlini MG; Ferguson DM; Portoghese PS
    J Med Chem; 2001 Mar; 44(6):857-62. PubMed ID: 11300867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular modeling study of the mechanism of ligand binding to human melatonin receptors.
    Voronkov AE; Ivanov AA; Baskin II; Palyulin VA; Zefirov NS
    Dokl Biochem Biophys; 2005; 403():284-8. PubMed ID: 16229143
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.